Literature DB >> 8970599

Malignant melanoma: the role of radiation therapy revisited.

J M Jenrette1.   

Abstract

In a multidisciplinary approach to the treatment of malignant melanoma, the role of radiation therapy is often relegated to one of minor importance. There is a supporting body of scientific literature that shows a relative radioresistance of melanoma when compared with other malignancies. Others have disputed the notion of resistance and have recommended radiation in a number of clinical settings including not only palliation but also in the primary management of melanoma. This article reviews the current and historical literature to better define the current role of radiation in a multidisciplinary approach for cancer management.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970599

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  8 in total

Review 1.  The evolving role of radiation therapy in the management of malignant melanoma.

Authors:  Niloufer Khan; Mohammad K Khan; Alex Almasan; Arun D Singh; Roger Macklis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-12       Impact factor: 7.038

2.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery.

Authors:  Charles E Rutter; Kimberly L Johung; Xiaopan Yao; Alex Y Lu; Lucia B Jilaveanu; James B Yu; Joseph N Contessa; Harriet M Kluger; Veronica L S Chiang; Ranjit S Bindra
Journal:  J Radiosurg SBRT       Date:  2016

4.  Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.

Authors:  Mohammad K Khan; Niloufer Khan; Alex Almasan; Roger Macklis
Journal:  Onco Targets Ther       Date:  2011-08-09       Impact factor: 4.147

5.  Integrin alphav-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen.

Authors:  Wenjie Bao; Staffan Strömblad
Journal:  J Cell Biol       Date:  2004-11-22       Impact factor: 10.539

6.  CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis.

Authors:  Y M Luo; N X Xia; L Yang; Z Li; H Yang; H J Yu; Y Liu; H Lei; F X Zhou; C H Xie; Y F Zhou
Journal:  Int J Mol Med       Date:  2014-04-02       Impact factor: 4.101

7.  2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis.

Authors:  Hong Zhao; Huangang Jiang; Zheng Li; Yafei Zhuang; Yinyin Liu; Shuliang Zhou; Youde Xiao; Conghua Xie; Fuxiang Zhou; Yunfeng Zhou
Journal:  Int J Oncol       Date:  2017-03-22       Impact factor: 5.650

8.  miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.

Authors:  Adriana Taveira da Cruz; Aline Hunger; Fabiana Henriques Machado de Melo; Ana Carolina Monteiro; Geneviève Catherine Paré; Dulce Lai; Débora Kristina Alves-Fernandes; Ana Luisa Pedroso Ayub; Esteban Mauricio Cordero; José Franco da Silveira Filho; Regine Schneider-Stock; Bryan Eric Strauss; Victor Tron; Miriam Galvonas Jasiulionis
Journal:  Neoplasia       Date:  2021-07-08       Impact factor: 5.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.